Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-30 Mitchener Stephen SVP, Chief Business Officer Exercise or conversion · Restricted Stock Units −1,500 1,500
2021-05-21 Schor Chen Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 PAKIANATHAN DEEPIKA Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 Oliger Christy J. Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 Mirza Mansoor Raza Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 Greene Barry E Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 Dolsten Mikael Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-21 BOHLIN GAREN G Director Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900
2021-05-07 Shah Jatin EVP, Chief Medical Officer Purchase +23,250 $8.60 $200K 131,802
2021-05-06 BOHLIN GAREN G Director Purchase +4,000 $7.82 $31K 4,000
2021-05-03 Paulson Richard A. President and CEO Grant or award +373,200 373,200
2021-05-03 Paulson Richard A. President and CEO Grant or award · Stock Option (right to buy) +559,800 559,800
2021-03-18 Shacham Sharon President & CSO Sale −4,000 $12.39 $50K 714,826
2021-03-18 Kauffman Michael Chief Executive Officer Sale −4,000 $12.39 $50K 714,826
2021-02-25 Shah Jatin EVP, Chief Medical Officer Grant or award +22,013 107,691
2021-02-25 Shah Jatin EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +59,968 59,968
2021-02-25 Mason Michael SVP, CFO & Treasurer Grant or award +22,013 51,755
2021-02-25 Mason Michael SVP, CFO & Treasurer Grant or award · Stock Option (right to buy) +59,968 59,968
2021-02-25 Lewis Tanya EVP, Chief Reg. Affairs Grant or award +22,013 45,401
2021-02-25 Lewis Tanya EVP, Chief Reg. Affairs Grant or award · Stock Option (right to buy) +59,968 59,968

Page 16 of 29 · 570 trades